ADEPTRIX CORP
TauTrace™ — an ultrasensitive immunoassay platform using lanthanide-labeled antibodies and Secondary Ion Mass Spectrometry (SIMS) detection to quantify phosphorylated tau proteoforms in blood and cere
- Sector
- Medtech
- Total capital
- $8.4M
- Federal grants
- $8.4M
- 10 awards · 2015–2025
- Rank in peer group#97 of 112
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 5
- 10 pending · first 2022
- Rank in peer group#10 of 112
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · TauTrace™: An ultrasensitive immunoassay for neurodegenerative protein biomarkers$500K
- Federal grantHealth and Human S · Phase I · Immunoassay for Measuring Mutation Activated Kinases Across Multiple Cell Signaling Pathways$295K
- Federal grantHealth and Human S · Phase II · HistoneScan™: a multiplex immunoassay for histone epigenetic profiling$437K
- Federal grantHealth and Human S · Phase II · Multiplexed immunoassay for building patient-specific molecular profiles of CSF amyloid beta and TAU$1.4M
- Federal grantHealth and Human S · Phase II · Multiplexed immunoassay for building patient-specific molecular profiles of CSF amyloid beta and TAU$1M
- Federal grantHealth and Human S · Phase II · HistoneScan™: a multiplex immunoassay for histone epigenetic profiling$833K
- Federal grantHealth and Human S · Phase II · Peptide Bead Microarrays Measured By Mass Spectrometry Imaging$740K
Show 3 earlier federal awards
- Federal grantHealth and Human S · Phase II · Peptide Bead Microarrays Measured By Mass Spectrometry Imaging$1.5M
- Federal grantHealth and Human S · Phase II · Peptide Bead Microarrays Measured By Mass Spectrometry Imaging$720K
- Federal grantNSF · Phase II · SBIR Phase II: A dual mass spectrometry and fluorescence microarray platform for proteomics$910K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 112 peers
Line = medianMedtech · Instrument
- Federal grantsBelow median
- Granted patents#10 · top 9%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 5 granted of 15- GrantedMultiplexed Bead-based Analytical AssaysUSPTOUS 12,467,930
- GrantedBead-based Assays For Protein AnalysisUSPTOUS 12,019,070
- GrantedMultiplexed Bead-based Analytical AssaysUSPTOUS 11,913,964
Show all 15 patent records
- Multiplexed Bead-based Analytical AssaysNov 11, 2025 · US 12,467,930Granted
- Bead-based Assays For Protein AnalysisJun 25, 2024 · US 12,019,070Granted
- Multiplexed Bead-based Analytical AssaysFeb 27, 2024 · US 11,913,964Granted
- Multiplexed Bead-based Analytical AssaysAug 17, 2023 · Application 18187372Pending
- Multiplexed Bead-based Analytical AssaysMay 2, 2023 · US 11,639,938Granted
- Multiplexed Bead Arrays For ProteomicsDec 1, 2022 · Application 17838666Pending
- Multiplexed Bead Arrays For ProteomicsJul 19, 2022 · US 11,391,729Granted
- Microarray Compositions And Methods Of Their UseApr 28, 2022 · Application 17462161Pending
- Devices And Methods For Producing And Analyzing MicroarraysJan 14, 2016 · Application 14795346Pending
- Devices And Methods For Producing And Analyzing MicroarraysApplication PCTUS2012024512Pending
- Multiplexed Bead-based Analytical AssaysApplication PCTUS2021020016Pending
- Bead-based Assays For Protein AnalysisApplication PCTUS2020066275Pending
- Bead-based Assays For Protein AnalysisApplication PCTUS2020066166Pending
- Multiplexed Bead-based Analytical AssaysApplication PCTUS2020042689Pending
- Multiplexed Bead Arrays For ProteomicsApplication PCTUS2018049995Pending
Related companies, and why
- InnoventricSimilar federal contract value in Medtech · null in contracts
- SOSTOS LLCSimilar federal contract value in Medtech · null in contracts
- SONOVOICE, INC.Similar federal contract value in Medtech · null in contracts
- OtoNexus Medical Technologies, Inc.Similar federal contract value in Medtech · null in contracts
- QUALIA OTO, INC.Similar federal contract value in Medtech · null in contracts
- BIOSYNTAGMA, LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .